A Randomized, Double-Blind, Parallel Group, Comparative Study of Flexibly Dosed Paliperidone Palmitate (25, 50, 75, or 100 mg eq.) Administered Every 4 Weeks and Flexibly Dosed RISPERDAL CONSTA (25, 37.5, or 50 mg) Administered Every 2 Weeks in Subjects With Schizophrenia
收藏DataCite Commons2026-04-14 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00004628/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to compare the effectiveness and safety over 1 year of treatment of intramuscular injections of paliperidone palmitate and long-acting risperidone in patients with schizophrenia.
提供机构：
Vivli
创建时间：
2019-09-19
